← All companies
ALNYLAM PHARMACEUTICALS, INC.
ALNY - CIK 0001178670
Market cap$37.51 B
Rank#405
SEC filings1,651
The table below shows ALNYLAM PHARMACEUTICALS, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.49B | $1.11B | $1.02B | $1.10B | $968.49M | $681.88M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $964.77M | $567.11M | $418.04M | $353.85M | $309.48M | $321.38M |
| Inventory | $75.38M | $71.69M | $65.58M | $75.99M | $83.98M | $93.99M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.